James M. Mock - 27 Feb 2026 Form 4 Insider Report for Moderna, Inc. (MRNA)

Role
Chief Financial Officer
Signature
/s/ James Dillon, As Attorney-in-Fact
Issuer symbol
MRNA
Transactions as of
27 Feb 2026
Net transactions value
-$275,252
Form type
4
Filing time
03 Mar 2026, 16:04:51 UTC
Previous filing
13 Feb 2026
Next filing
06 Mar 2026
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Mock James M Chief Financial Officer C/O MODERNA, INC., 325 BINNEY STREET, CAMBRIDGE /s/ James Dillon, As Attorney-in-Fact 03 Mar 2026 0001736359

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction MRNA Common Stock Options Exercise +329 +0.73% 45,553 27 Feb 2026 Direct F1
transaction MRNA Common Stock Tax liability $8,274 -160 -0.35% $51.71 45,393 27 Feb 2026 Direct F2
transaction MRNA Common Stock Options Exercise +774 +1.7% 46,167 27 Feb 2026 Direct F1
transaction MRNA Common Stock Tax liability $19,391 -375 -0.81% $51.71 45,792 27 Feb 2026 Direct F2
transaction MRNA Common Stock Options Exercise +9,901 +22% 55,693 27 Feb 2026 Direct F1
transaction MRNA Common Stock Tax liability $247,587 -4,788 -8.6% $51.71 50,905 27 Feb 2026 Direct F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction MRNA Restricted Stock Units Options Exercise $0 -329 -20% $0.000000 1,315 27 Feb 2026 Common Stock 329 Direct F1, F3
transaction MRNA Restricted Stock Units Options Exercise $0 -774 -11% $0.000000 6,189 27 Feb 2026 Common Stock 774 Direct F1, F4
transaction MRNA Restricted Stock Units Options Exercise $0 -9,901 -25% $0.000000 29,705 27 Feb 2026 Common Stock 9,901 Direct F1, F5
transaction MRNA Stock Option (Right to Buy) Award $0 +37,639 $0.000000 37,639 01 Mar 2026 Common Stock 37,639 $53.57 Direct F6
transaction MRNA Restricted Stock Units Award $0 +49,569 $0.000000 49,569 01 Mar 2026 Common Stock 49,569 Direct F1, F7
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Restricted stock units convert into common stock on a one-for-one basis.
F2 Represents shares withheld at the election of the Reporting Person to satisfy tax withholding obligations in connection with the vest of restricted stock units.
F3 25% of the shares subject to this restricted stock unit award vested on February 28, 2024 with the remainder vesting in twelve (12) equal quarterly installments thereafter.
F4 25% of the shares subject to this restricted stock unit award vested on February 27, 2025 with the remainder vesting in twelve (12) equal quarterly installments thereafter.
F5 25% of the shares subject to this restricted stock unit award vested on March 1, 2026 with the remainder vesting in twelve (12) equal quarterly installments thereafter.
F6 25% of this option will vest and become exercisable on March 1, 2027 with the remainder vesting in twelve (12) equal quarterly installments thereafter.
F7 25% of the shares subject to this restricted stock unit award will vest on March 1, 2027 with the remainder vesting in twelve (12) equal quarterly installments thereafter.